301 related articles for article (PubMed ID: 4885374)
1. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
2. [Experiences with N-Lost phosphamide esters].
Drings P; Allner R; Brock N; Burkert H; Fischer M; Fölsch E; Gerhartz H; Götzky P; Hoppe I; Kanzler G; Klein HO; Mainzer K; Martin H; Obrecht P; Palme G; Paulisch H; Riegg H; Schubert JC; Treske U; Weise W; Willems D; Wilmanns H; Witte S; Wohlenberg H
Dtsch Med Wochenschr; 1970 Mar; 95(10):491-7. PubMed ID: 4905291
[No Abstract] [Full Text] [Related]
3. Trenimon treatment in chronic hemoblastoses.
Quattrin N; Dini E; Montuori R
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):145-52. PubMed ID: 4968994
[No Abstract] [Full Text] [Related]
4. [Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
Kühböck J; Mannheimer E; Pietschmann H
Wien Klin Wochenschr; 1966 Dec; 78(48):841-4. PubMed ID: 4291623
[No Abstract] [Full Text] [Related]
5. [Secondary tumors in hemoblastoses during cytostatic treatment].
Hartwich G; Butzler W
Med Klin; 1971 Oct; 66(43):1445-50. PubMed ID: 5001553
[No Abstract] [Full Text] [Related]
6. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
7. [Results obtained with the clinical use of adriamycin].
Esposito S; Taylor LA
Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
[No Abstract] [Full Text] [Related]
8. Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
Hindy I; Sellei C; Eckhardt S; Szentklãray J; Hartai F
Neoplasma; 1971; 18(3):277-82. PubMed ID: 4937513
[No Abstract] [Full Text] [Related]
9. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
10. Midwest cooperative group evaluation of piposulfan (A-20968) in cancer.
Nelson NA; Talley RW; Reed ML; Evans AM; Isaacs BL; Huffman P; Louis J
Clin Pharmacol Ther; 1967; 8(3):385-91. PubMed ID: 5338383
[No Abstract] [Full Text] [Related]
11. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
12. [Cytostatic therapy of malignant reticuloses and retothelial sarcomatoses].
Buss D; Günther I; Konrad H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):207-14. PubMed ID: 4122847
[No Abstract] [Full Text] [Related]
13. [Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors].
Kenis Y
Acta Clin Belg; 1968; 23(2):103-13. PubMed ID: 4914032
[No Abstract] [Full Text] [Related]
14. [Mithramycin therapy of hypercalcemia in patients with neoplastic diseases].
Skovgaard M
Ugeskr Laeger; 1974 Aug; 136(32):1814-7. PubMed ID: 4277881
[No Abstract] [Full Text] [Related]
15. [Ixoten therapy in malignant lymphomas].
Pötzi P; Aiginger P; Kühböck J
Acta Med Austriaca; 1979; 6(5):247-9. PubMed ID: 400215
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
17. [Rehabilitation and cure of patients with hemoblastoses].
Gerhartz H
Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782
[No Abstract] [Full Text] [Related]
18. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Marcolongo R; Bianco G; Di Paolo N; Bravi A
Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
[No Abstract] [Full Text] [Related]
19. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
[No Abstract] [Full Text] [Related]
20. [Intermittent high-dosage cyclophosphamide therapy].
Sakalová A; Kvietková V; Lichý D; Sámel M
Bratisl Lek Listy; 1970 Mar; 53(3):329-32. PubMed ID: 4909013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
